-
Conferences & Events
- Upcoming Conferences & Events
- Upcoming
-
Past Conferences
- ISPOR Europe 2022
- ISPOR Asia Pacific 2022
- Signal - 2022 - 08
- Signal - 2022 - 07
- ISPOR 2022
- Signal - 2022 - 06
- Signal - 2021 - 04
- ISPOR Europe 2021
- Signal - 2021 - 05
- ISPOR Latin America Summit 2021
- Signal - 2021 - 03
- Signal - 2021 - 02
- ISPOR Summit 2021
- ISPOR 2021
- Signal - 2021 - 01
- ISPOR Europe 2020
- ISPOR-FDA Summit 2020
- ISPOR Asia Pacific 2020
- ISPOR 2020
- ISPOR Europe 2019
- ISPOR Europe 2018
- Past
- Abstract Information
- Awards & Grants
- Exhibits & Sponsorships
- Register
- 2022-2023 Press Kit
- Education
- Calendar
Faculty
Course Description
This module is an introduction to the role of pharmacoeconomics (PE) in medical decision making from multiple perspectives. It will introduce the concepts of types of PE/Cost-effectiveness analysis (CEA), general computation involved in these analyses, and how to evaluate a CEA.
Learning Objectives
By the end of the Introduction to Pharmacoeconomics (PE) module, you will be able to:
- State the role of PE in medical decision making.
- Define the types of PE/cost-effectiveness analyses (CEA).
- Explain the societal, patient and payer tradeoffs involved in using PE for medical decision making.
- Understand the difference between and usefulness of average and incremental (marginal) CEA.
- State the definition of utility measurement and its use in cost-utility analysis.
- Understand the elements essential to a published CEA.